Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Medibio.
RELATED STOCKHEAD STORIES
News
Top 10 at 10: Positive phase 1 trials and a $21m US govt contract
News
Market Highlights: What Dow Jones’ 10-day winning streak means; and big week ahead for interest rates
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Health & Biotech
ASX Health Stocks: Polynovo leaps 12pc after coming out of trading halt, gets FDA approval
Health & Biotech
Check Up: Here’s what’s in store for the Healthcare sector as the new government steps in
Health & Biotech
Who got what in the healthcare budget, and which ASX stocks could benefit
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
News
Rise and Shine: What you need to know before the ASX opens
News
ASX Small Cap Lunch Wrap: Who’s benefited from Elon’s US$250 billion touch this morning?
Health & Biotech
ASX Health Stocks: Resapp gains on India COVID-19 trial, Atomo to supply HIV self-test in Australia
News
Market highlights and 5 ASX small caps to watch on Friday
Tech
$118m and a ‘Patent Box’: Here are the AI stocks looking to make the most of the Budget
News
WFH is here to stay. But which ASX stocks will stay to benefit?
Tech
Telehealth Oneview rises by 400pc in two weeks; how will other ASX wellness stocks play out post-COVID?
News
Last Orders: Small caps dip 0.5%, but finish week in the green
News
